Including both Wegovy and Ozempic injections, our weight loss program provides a comprehensive approach
While you sleep, your brain does much more than rest
The approved NHS pathways are: Wegovy (semaglutide) licensed for weight management via NICE TA875 (BMI 35+ with one condition, via tier 3 services) and NICE cardiovascular guidance April 2026 (BMI 27+ with established CVD, via GP) Mounjaro (tirzepatide) licensed for weight management via NICE TA1026 (BMI 35+ with four conditions from June 2026, via tier 3 or QOF GP pathway) Ozempic (semaglutide) NOT approved for NHS weight management
[3] Research shows ALCAR increases cerebral glucose metabolism by 21-22% in key brain regions, with enhanced cholinergic neurotransmission supporting cognitive function
While many weight loss medications rely on suppressing your appetite for a short period, Cagrilintide works over time to reduce your desire to overeat, helping you relearn healthy eating habits and maintain lasting weight loss
International Journal of Women's Dermatology (2020)